tratamento e sua comparação com as basais podem indicar atividade da doença res de fase aguda, anemia de doença crônica, hipoalbuminemia, fator. sidade de diagnostico e tratamento corretos que possam garantir o sucesso desse tipo de terapia .. presença de hipoalbuminemia, anemia, edema, astenia e. e Sais Biliares/farmacocinética Colestase/tratamento farmacológico Hipoalbuminemia/tratamento farmacológico Hidrocortisona/secreção Cortisona/ secreção.
|Published (Last):||15 February 2005|
|PDF File Size:||18.39 Mb|
|ePub File Size:||14.65 Mb|
|Price:||Free* [*Free Regsitration Required]|
Os aneurismas gigantes e persistentes evoluem mais frequentemente com estenose.
There was a problem providing the content you requested
A IGIV pode acarretar alguns efeitos colaterais menores como sintomas vasomotores: Pediatr Trata,ento Dis J. Chung CJ, Stein L. Diagnosis and therapy of Kawasaki disease in children. Diagnosis, management, and long-term implications.
Kawasaki disease in Korea, Association between a novel human coronavirus and Kawasaki Disease. New developments in the search for the etiologic agent of Kawasaki disease. Curr Opin in Pediatr. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. Proft T, Fraser JD. Llewelyn M, Cohen J.
Matsubara K, Fukaya T. The role of tratamsnto of group A Streptococcus and Staphylococcus aureus in Kawasaki disease.
Curr Opin Infect Dis. Prevalence of superantigensecreting bacteria in patients with Kawasaki Disease. Oligoclonal IgA response in the vascular wall in acute Kawasaki tfatamento. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki Disease. Candidate genes for susceptibility to Kawasaki disease KD: Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.
J Clin Lab Anal. TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. S Proteins in the Pathogenesis of Kawasaki Disease. J Am Coll Hipolbuminemia. Pathogenesis and treatment of Kawasaki’s disease. Early diagnosis of Kawasaki disease in patients with cervical linphadenopathy.
Difficulties in the Diagnosis of Kawasaki Disease.
General review and problems in Kawasaki Disease. Textbook of pediatric rheumatology. Pustular rash in Kawasaki syndrome. Pustulo-vesicular skin eruption in a child with probable Kawasaki disease.
J Gen Intern Med.
Kawasaki disease in the adult: Tex Heart Inst J. Abnormal myocardial mechanics in Kawasaki disease: Long-term consequences of Kawasaki disease: Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. The riddle of Kawasaki disease.
N Engl J Med ; Coronary artery evaluation in Kawasaki disease by dual source multidetector CT coronary angiography in children. Myocardial infarction in pregnancy. Pregnancy and delivery in patients with coronary artery lesions caused by Kawasaki disease.
Recurrent toxin-mediated perineal erythema: Myocardial infarction in Kawasaki disease: Vasodilatory response of the coronary arteries after Kawasaki disease: Long term consequences of regressed coronary aneurysms after Kawasaki disease: Sequelae of Kawasaki disease in adolescents and young adults. Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography.
Int Heart J ; Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. The prevention of coronary artery aneurysm in Kawasaki disease: Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.
High-dose intravenous immunoglobulin downregulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki disease. Kawasaki disease with severe cardiac sequelae: J Paediatr Child Health.
Gene expression profiling of the effect of highdose intravenous Ig in patients with Kawasaki disease. Gamma-globulin- induced modulation with necrotic-like morphology of peripheral blood neutrophils. Early intravenous gamma-globulin treatment for Kawasaki disease: Evaluation of the efficacy of treatment of Kawasaki disease before day 5 of illness.
Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion. American Academy of Pediatrics; Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. Is there a role for corticosteroids in Kawasaki disease? Immunoglobulin failure and retreatment in Kawasaki disease. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatric Infect Dis J ; Plasma exchange for refractory Kawasaki disease. Treatment of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate.
A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate.
Portal Regional da BVS
Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Infliximab treatment for refractory Kawasaki disease with coronary artery aneurysm. Nenhum Como citar este artigo: All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.
Services on Demand Journal. Rio Branco, 39 How to cite this article.